News & Events

TransAlgae is a biotech company that has developed a breakthrough technology for oral delivery of drugs and vaccines, based on genetic engineering of algae. TransAlgae's technology makes the use of injections redundant. The technology is based on rapid and flexible pro...

TransAlgae is a member of a large European consortium that has recently been awarded an €8.3M H2020 grant from the EU’s “Plant Molecular Factory” call. 

The 4-year project called “Pharma Factory” will focus on advancing the production of pharmaceutical proteins and bio-...

When it comes to putting healthy fish on the dinner table, experts believe vaccination is the way to go.

TransAlgae was at the Animal Health Investment – Europe Our CTO, Dr. Ofra Chen presented at the forum - 22nd-23rd February, 2017
Millennium Hotel London Mayfair, UK.

Animal health investment website

The January 2017 BioNetworking Event featured Ofra Chen, Ph.D. from Israeli biotechnology company, TransAlgae. Dr. Chen presented a lecture entitled, "Algae Based Oral Vaccines - Applications for Aquaculture"
The Atlantic Technology Center, lower level theater, 176 Gre...